Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort

被引：0
|
作者：
Bruno Fautrel
Benjamin Granger
Bernard Combe
Alain Saraux
Francis Guillemin
Xavier Le Loet
机构：
[1] Université Pierre et Marie Curie (UPMC) - Paris 6,Department of Rheumatology
[2] GRC-08 EEMOIS; AP-HP Pitié Salpêtrière Hospital,Department of Rheumatology, Lapeyronie Hospital
[3] Montpellier I University,Rheumatology Department
[4] Brest University; Department of Rheumatology,undefined
[5] La Cavale Blanche University Hospital,undefined
[6] Lorraine University,undefined
[7] Paris-Descartes University,undefined
[8] EA 4360 APEMAC -- Inserm,undefined
[9] CIC-EC CIE6,undefined
[10] CHU de Brabois,undefined
[11] Rouen University Hospital & INSERM U905,undefined
[12] Institute for Research and Innovation in Biomedicine,undefined
[13] Rouen University,undefined
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Rheumatoid Arthritis; Leflunomide; Early Rheumatoid Arthritis; Swell Joint Count; Swell Joint Count;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort
    Beltai, Aurelie
    Combe, Bernard
    Coffy, Amandine
    Gaujoux-Viala, Cecile
    Lukas, Cedric
    Saraux, Alain
    Dougados, Maxime
    Daures, Jean Pierre
    Hua, Charlotte
    JOINT BONE SPINE, 2022, 89 (03)
  • [32] Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
    Rydell, Emil
    Forslind, Kristina
    Nilsson, Jan-Ake
    Jacobsson, Lennart T. H.
    Turesson, Carl
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [33] Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
    Emil Rydell
    Kristina Forslind
    Jan-Åke Nilsson
    Lennart T. H. Jacobsson
    Carl Turesson
    Arthritis Research & Therapy, 20
  • [34] Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort
    Gaujoux-Viala, Cecile
    Rat, Anne-Christine
    Guillemin, Francis
    Flipo, Rene-Marc
    Fardellone, Patrice
    Bourgeois, Pierre
    Fautrel, Bruno
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (09) : 1478 - 1483
  • [35] Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial
    S Aslibekyan
    E E Brown
    R J Reynolds
    D T Redden
    S Morgan
    J E Baggott
    J Sha
    L W Moreland
    J R O'Dell
    J R Curtis
    T R Mikuls
    S L Bridges
    D K Arnett
    The Pharmacogenomics Journal, 2014, 14 : 48 - 53
  • [36] Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial
    Aslibekyan, S.
    Brown, E. E.
    Reynolds, R. J.
    Redden, D. T.
    Morgan, S.
    Baggott, J. E.
    Sha, J.
    Moreland, L. W.
    O'Dell, J. R.
    Curtis, J. R.
    Mikuls, T. R.
    Bridges, S. L., Jr.
    Arnett, D. K.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (01) : 48 - 53
  • [37] Relative Clinical Influence of Clinical, Laboratory, and Radiological Investigations in Early Arthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis Cohort ESPOIR
    Gossec, Laure
    Combescure, Christophe
    Rincheval, Nathalie
    Saraux, Alain
    Combe, Bernard
    Dougados, Maxime
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (12) : 2486 - 2492
  • [38] Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
    Nishina, Naoshi
    Kaneko, Yuko
    Kameda, Hideto
    Kuwana, Masataka
    Takeuchi, Tsutomu
    CLINICAL RHEUMATOLOGY, 2013, 32 (11) : 1661 - 1666
  • [39] Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
    Naoshi Nishina
    Yuko Kaneko
    Hideto Kameda
    Masataka Kuwana
    Tsutomu Takeuchi
    Clinical Rheumatology, 2013, 32 : 1661 - 1666
  • [40] Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial
    Tamai, Hiroya
    Ikeda, Kei
    Miyamoto, Toshiaki
    Taguchi, Hiroaki
    Kuo, Chang-Fu
    Shin, Kichul
    Hirata, Shintaro
    Okano, Yutaka
    Sato, Shinji
    Yasuoka, Hidekata
    Kuwana, Masataka
    Ishii, Tomonori
    Kameda, Hideto
    Kojima, Toshihisa
    Nishi, Yurie
    Mori, Masahiko
    Miyagishi, Hideaki
    Toshima, Genta
    Sato, Yasunori
    Tsai, Wen-Chan
    Takeuchi, Tsutomu
    Kaneko, Yuko
    MIRACLE Study Grp, M. I. R. A. C. L. E. Study Group
    ANNALS OF THE RHEUMATIC DISEASES, 2025, 84 (01)
12345